openPR Logo
Press release

Increase in Frequency of Product Innovations to Drive the Small RNA Detection Market from 2020 to 2030

10-21-2020 10:16 AM CET | Health & Medicine

Press release from: Persistence Market Research

Small RNA is a class of non-coding RNA that plays a major role in the regulation of gene expressions. Small RNA works at the post-transcription level and modify the expression of around 30% of all mammalian protein-encoding genes. Small RNA detection is performed to determine the role of small RNA, useful in the diagnosis and treatment of various diseases. The global small RNA detection market is likely to expand during the forecast period due to the increasing prevalence of cancer and other chronic disorders, and rising research to explore the role of small RNAs in the diagnosis and treatment of the disease.
The outbreak of coronavirus is a shock to the world’s economy. It has caused a huge disturbance in almost all industries. As coronavirus has become the main focus, all research institutes, biotech and pharmaceutical companies are appointed in collaboration work to deal with Covid-19. This led to the shifting of their focus and also all the resources from making other drugs to coronavirus vaccines. This is hampering the growth of the global small RNA detection market.

To remain ‘ahead’ of your competitors, request for a sample here@ https://www.persistencemarketresearch.com/samples/31994

Small RNA Detection Market: Drivers and Restraints-
The increasing prevalence of cancer and cardiovascular diseases is the major driver of the global small RNA detection market growth. Cancer is the leading cause of death in Canada that accounts for around 30% of the total deaths and this count is expected to increase in the future across the globe. Hence, there is an urgent need for cancer detection and effective diagnosis technology. Furthermore, the increasing use of technologically advanced systems and bioinformatics is likely to boost the growth of the global small RNA detection market. However, the difficulties related to the development of in-house small RNA detection tools such as microarrays, and quantification are expected to restrain small RNA detection market growth.

Request For Table of Content (TOC) @ https://www.persistencemarketresearch.com/toc/31994

Small RNA Detection Market: Segmentation
Based on the method type, the global small RNA detection market can be segmented as:
• Microarrays
• Next-generation Sequencing
• Northern Blotting
• Quantitative real-time PCR
• In situ Hybridization
Based on the application, the global small RNA detection market can be segmented as:
• Cancer
• Infectious Diseases
• Cardiovascular Disease
• Neurological Disease
• Immunological Disorder
Based on the end-user, the global small RNA detection market can be segmented as:
• Biotech Companies
• Academic and Research Institutes
Small RNA Detection Market: Overview
Based on the method type, the quantitative real-time PCR tool segment is expected to hold a major share in the small RNA detection market due to its quantitative and high sensitivity nature. Based on the application, the cancer segment is expected to dominate the small RNA detection market due to the increasing prevalence of the disease across the globe. Based on the end-user, biotech companies are expected to be the most dominating segment in the global small RNA detection market due to the increase in research undertaken.
Small RNA Detection Market: Region-wise Outlook
The global small RNA detection market is expected to be dominated by North America, due to the increasing advancement in the technology and ongoing research in the region. Europe is expected to be the next most dominant region, due to the rising biotech companies in the region and rising investments by the government. Asia-Pacific is expected to have a significant growth in the global small RNA detection market over the forecast period due to the rising incidence of cancer and other chronic disorders and rising investment by foreign countries in India and China. Furthermore, the increase in research undertaken to explore the role of small RNAs in the development, diagnosis, and treatment of diseases is likely to drive the small RNA detection market in the region.
Small RNA Detection Market: Key Market Participants
Some of the market players in the global small RNA detection market identified across the value chain include: Roche Holding AG, Thermo Fisher Scientific, WIN Semiconductors Corp., QIAGEN, Agilent Technologies, Inc., and others.
The report covers exhaust analysis on:
• Small RNA Detection Market Segments
• Small RNA Detection Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain
Regional analysis includes:
• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (India, ASEAN, Australia & New Zealand)
• China
• Japan
• Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

You can access Full report here @ https://www.persistencemarketresearch.com/checkout/31994

Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
USA - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com

Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PMR.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increase in Frequency of Product Innovations to Drive the Small RNA Detection Market from 2020 to 2030 here

News-ID: 2166461 • Views: 189

More Releases from Persistence Market Research

Technology Advancing at a Rapid Pace to Drive the Cell Banking Outsourcing Marke …
A cell bank refers to a facility that store cells derived from various body fluids and organ tissue for future needs. The bank store the cells with detailed characterization of the cell line hence decrease the chances of cross contamination. Cell banking outsourcing industry involves collection, storage, characterization, and testing of cells, cell lines, and tissues. Cell banks provide cells, cell lines, and tissues for R&D, production of biopharmaceuticals with
The Electron Microscopy Sample Preparation Market to Continue to be Incremental …
Electron microscopes use accelerated beams of electrons as source of illumination. Resolving power of electron microscope is much higher than light microscope and thus electron microscope can magnify even the smallest structure of the sample. Electron microscope has the efficiency to produce resolution up to 50 Pico meter and magnification up to 10,000,000x. These high specifications make every detail of the sample clearly visible. Sample preparation is the initial operation
The Flavoured Veterinary Medications Market to record a remarkable growth in the …
Flavored Veterinary Medications are the medicines available in different flavors for the diagnosis, treatment and prevention of diseases in animals or birds. Veterinarians give the right advice to pet owners to take proper care of their pets and the right medication too. Sometimes a problem arises that pets are do not intake proper medication because of the taste. For example cats don’t like pills but like tuna, dogs don’t like
Incremental Sales to Drive the Sleep Disorder Therapeutics Market from 2020 to 2 …
Sleep disorders include a variety of complications related to sleep and have a high prevalence across the globe. Based on these complications, sleep disorders can be classified into three categories- lack of sleep which includes insomnia, excessive sleep which includes narcolepsy and disturbed sleep which include sleep apnea and Rapid eye movement (REM) disorder. Insomnia may arise as result of unhealthy diet, emotional dreams, stress, and many other factors. Insomnia

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
RNA Drugs Global Industry Report - History, Present and Future 2025
The global market size of RNA Drugs is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and